About Veeda Lifesciences
Veeda Lifesciences is a company based in Ahmedabad (India) founded in 2004.. Veeda Lifesciences has raised $83.32 million across 8 funding rounds from investors including Actis, Acorn Capital and Systematix. The company has 902 employees as of November 04, 2024. Veeda Lifesciences offers products and services including Clinical Trials, Preclinical Services, Bioanalytical Services, and Real World Evidence. Veeda Lifesciences operates in a competitive market with competitors including Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others.
- Headquarter Ahmedabad, India
- Employees 902 as on 04 Nov, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Veeda Clinical Research Limited
- Date of Incorporation 23 Apr, 2004
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$50.52 M (USD)43.36as on Mar 31, 2023
-
Net Profit
$5.1 M (USD)-15.92as on Mar 31, 2023
-
EBITDA
$12.43 M (USD)68.37as on Mar 31, 2023
-
Total Equity Funding
$83.32 M (USD)
in 8 rounds
-
Latest Funding Round
$28.91 M (USD), Series B
May 12, 2023
-
Investors
Actis
& 34 more
-
Employee Count
902
as on Nov 04, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Veeda Lifesciences
Veeda Lifesciences offers a comprehensive portfolio of products and services, including Clinical Trials, Preclinical Services, Bioanalytical Services, and Real World Evidence. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Conducts Phase I-IV trials for drugs and biotherapeutics.
Offers testing from discovery to IND submission processes.
Provides method development and sample analysis for studies.
Uses real-world data for patient matching and trial insights.
Funding Insights of Veeda Lifesciences
Veeda Lifesciences has successfully raised a total of $83.32M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $28.91 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series B — $28.9M
-
First Round
First Round
(09 Feb 2007)
- Investors Count 35
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Series B - Veeda Lifesciences | Valuation | ValueQuest | |
| Dec, 2021 | Amount | Series B - Veeda Lifesciences | Valuation | Acorn Capital | |
| Mar, 2021 | Amount | Series B - Veeda Lifesciences | Valuation | QRG Investments and Holdings |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Veeda Lifesciences
Veeda Lifesciences has secured backing from 35 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Actis, Acorn Capital and Systematix. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment management services in growth equity and public investments in India.
|
Founded Year | Domain | Location | |
|
Private equity fund investing in healthcare businesses
|
Founded Year | Domain | Location | |
|
Sustainable infrastructure projects are invested in for essential services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Veeda Lifesciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Veeda Lifesciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Veeda Lifesciences Comparisons
Competitors of Veeda Lifesciences
Veeda Lifesciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, Cytel, LabCorp, Precision Medicine Group and Frontage Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| domain | founded_year | HQ Location |
Early drug development services are provided for pharma firms.
|
|
| domain | founded_year | HQ Location |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Veeda Lifesciences
Frequently Asked Questions about Veeda Lifesciences
When was Veeda Lifesciences founded?
Veeda Lifesciences was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Where is Veeda Lifesciences located?
Veeda Lifesciences is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Is Veeda Lifesciences a funded company?
Veeda Lifesciences is a funded company, having raised a total of $83.32M across 8 funding rounds to date. The company's 1st funding round was a Series B of $15.89M, raised on Feb 09, 2007.
How many employees does Veeda Lifesciences have?
As of Nov 04, 2024, the latest employee count at Veeda Lifesciences is 902.
What is the annual revenue of Veeda Lifesciences?
Annual revenue of Veeda Lifesciences is $50.52M as on Mar 31, 2023.
What does Veeda Lifesciences do?
Provider of end-to-end CRO solutions for bio pharmaceutical companies. It offers a range of services across the drug development lifecycle, including Preclinical studies, BioavailabilityBioequivalence studies, Early-phase clinical trials, Late-phase clinical trials, Bioanalytical, Clinical data management, Biostatistics, Pharmacovigilance, and Central bioanalytical.
Who are the top competitors of Veeda Lifesciences?
Veeda Lifesciences's top competitors include LabCorp, Charles River Laboratories and Cytel.
What products or services does Veeda Lifesciences offer?
Veeda Lifesciences offers Clinical Trials, Preclinical Services, Bioanalytical Services, and Real World Evidence.
Who are Veeda Lifesciences's investors?
Veeda Lifesciences has 35 investors. Key investors include Actis, Acorn Capital, Systematix, Ashoka India Equity Investment, and VLS Finance.
What is Veeda Lifesciences's valuation?
The valuation of Veeda Lifesciences is $270.54M as of May 2023.